Abstract:Interactions between tumor intrinsic factors and tumor microenvironment play a vital role in disease progression and treatment response. SOX9, a transcription factor crucial for tissue development and homeostasis, has been linked to the advancement of tumor growth. However, its specific role as a driver in lung adenocarcinoma (LUAD) is not well-defined. Additionally, the impact of SOX9 on the tumor microenvironment has not been previously explored. We here identify SOX9 transcription factor to play a critical role in defining tumor immune microenvironment and driving disease progression. We employed CRISPR/Cas9 and Cre-LoxP gene knockout methods within the Kras G12D-induced mouse model of lung adenocarcinoma (LUAD). Our objective was to investigate the mechanisms through which SOX9 contributes to the development and advancement of lung adenocarcinoma. To substantiate our findings, we conducted immune profiling, gene expression analyses, RT-qPCR, and immunohistochemistry assessments in the Kras G12D-driven murine LUAD. These results were subsequently validated by examining bulk and single-cell gene expression profiles, as well as immunohistochemistry, in human lung adenocarcinoma. Our studies indicated that SOX9 played a very important role by enhancing lung tumor development, burden, and progression, leading to lower overall survival. SOX9. SOX9 consistently facilitated the growth of organoids in vitro. However, the promotion of tumor growth by SOX9 was notably reduced in immunocompromised mice compared to syngeneic mice. SOX9 demonstrated a suppressive effect on immune cell infiltration, particularly affecting the functionality of tumor-associated CD8+ T cells, natural killer cells, and dendritic cells. CD8+ T cells in the SOX9 overexpressing tumors showed upregulation of exhaustion markers. SOX9-mediated tumor growth advantage could not be observed in the CD8 knockout mice model, suggesting a CD8+ T cell-dependent role. In addition, SOX9 significantly upregulated collagen-related gene expression, leading to a substantial increase in collagen fibers possibly affecting the migration of immune cells into the tumor microenvironment. Together, our studies indicate that SOX9 plays a very critical role in modulating tumor microenvironment by controlling immune cell infiltration and CD8+ T cell exhaustion driving Kras G12D- driven lung tumor progression. Citation Format: Dinoop Ravindran Menon, Hua Zhong, Shridar Ganesan, Hatim Sabaawy, Sharon Pine. SOX9-dependent immune microenvironment remodeling drives KRAS-induced lung adenocarcinoma progression [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 5352.

Upregulation of SOX9 promotes cell proliferation, migration and invasion in lung adenocarcinoma.

SOX5 Predicts Poor Prognosis in Lung Adenocarcinoma and Promotes Tumor Metastasis Through Epithelial-Mesenchymal Transition

SOX5 Induces Lung Adenocarcinoma Angiogenesis by Inducing the Expression of VEGF Through STAT3 Signaling

Upregulation of sex-determining region Y-box 9 (SOX9) promotes cell proliferation and tumorigenicity in esophageal squamous cell carcinoma

Sox9 Mediates Notch1-induced Mesenchymal Features in Lung Adenocarcinoma

MiR-124 Inhibits Cell Proliferation, Migration and Invasion by Directly Targeting SOX9 in Lung Adenocarcinoma.

Analysis of SOX9 Expression in Colorectal Cancer.

SOX2 Gene Regulates the Transcriptional Network of Oncogenes and Affects Tumorigenesis of Human Lung Cancer Cells.

Expression of SOX9 in Colorectal Cancer and Its Significance

Decreased Expression of SOX7 is Correlated with Poor Prognosis in Lung Adenocarcinoma Patients

SOX9 drives KRAS-induced lung adenocarcinoma progression and suppresses anti-tumor immunity

PAX9 Overexpression in Lung Adenocarcinoma and Promotes Cancer Progression

SOX4 promotes the growth and metastasis of breast cancer

High Expression of Transcriptional Factor HoxB9 Predicts Poor Prognosis in Patients with Lung Adenocarcinoma.

Downregulation of SOX9 suppresses breast cancer cell proliferation and migration by regulating apoptosis and cell cycle arrest

Abstract 5352: SOX9-dependent immune microenvironment remodeling drives KRAS-induced lung adenocarcinoma progression

Knockdown of Sox12 Expression Inhibits the Proliferation and Metastasis of Lung Cancer Cells

The transcriptional regulation of SOX2 on FOXA1 gene and its application in diagnosis of human breast and lung cancers.

Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment

DHX9 Inhibits Epithelial-Mesenchymal Transition in Human Lung Adenocarcinoma Cells by Regulating STAT3.

High expression of SOX30 is associated with favorable survival in human lung adenocarcinoma